Showing results (1631-1640 of 1,855) with videos related to

Sort By:
Pageof 186
Nuclear Medicine and Biology|July 1, 1995
Characterization of the dopamine transporter in nonhuman primate brain: homogenate binding, whole body imaging, and ex vivo autoradiography using [125I] and [123I]IPCITM S al-Tikriti, Y Zea-Ponce, R M Baldwin, et al.
American Journal of Clinical Oncology|June 1, 1983
Continuous vindesine infusion in advanced head and neck cancerJ D Popkin, R H Bromer, C W Vaughan, et al.
Neurology|April 1, 1992
"Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissueE W Johnson, N C de Lanerolle, J H Kim, et al.
Psychiatry Research|December 1, 1994
SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphineC H van Dyck, M I Rosen, H M Thomas, et al.
IEEE Transactions on Visualization and Computer Graphics|September 28, 2022
Visinity: Visual Spatial Neighborhood Analysis for Multiplexed Tissue Imaging DataSimon Warchol, Robert Krueger, Ajit Johnson Nirmal, et al.
Clinical Trials (London, England)|June 1, 2019
The Habit Formation trial of behavioral economic interventions to improve statin use and reduce the risk of cardiovascular disease: Rationale, design and methodologiesMary E Putt, Peter P Reese, Kevin G Volpp, et al.
Journal of Biophotonics|January 22, 2024
Smartphone-based detection of COVID-19 and associated pneumonia using thermal imaging and a transfer learning algorithmOshrit Hoffer, Rafael Y Brzezinski, Adam Ganim, et al.
World Neurosurgery|October 13, 2019
Morbidity and Mortality After Burr Hole Craniostomy Versus Craniotomy for Chronic Subdural Hematoma Evacuation: A Single-Center ExperienceAlankrita Raghavan, Gabriel Smith, Louisa Onyewadume, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transportersJ P Seibyl, M Laruelle, C H van Dyck, et al.
International Journal of Molecular Sciences|March 11, 2023
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's DiseaseTung-Tai Kuo, Yuan-Hao Chen, Vicki Wang, et al.
Pageof 186